HomeVIDA Diagnostics Inc.

VIDA Diagnostics Inc.

VIDA Completes Second Close Of Round C Financing

This investment augments an $11M investment round last month led by First Analysis Corporation and will further fuel the development and commercialization of VIDA's innovative solutions to impact patient care for both traditional respiratory diseases as well as emergent COVID-19 conditions.